Although a candidate birdflu vaccine has not yet been made commercially ... all we have to do is do this new strain," she added. In July 2024, Moderna was awarded $176 million from the U.S ...
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...